0102030405
CAS 330792-68-2 Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]- Pharmaceutical Intermediates
02
introduction
2-[Hydroxy-(4-phenoxy-phenyl)-Methylene]-Malononitrile is a specialty compound that is widely used as an intermediate in the pharmaceutical industry. This compound is essential for the synthesis of a variety of pharmaceutical agents, especially those targeting specific therapeutic areas.
As a factory integrating production and trading, we ensure that the production of Ibrutinib Intermediates meets the highest standards, providing reliable solutions for pharmaceutical manufacturers and researchers.
As a factory integrating production and trading, we ensure that the production of Ibrutinib Intermediates meets the highest standards, providing reliable solutions for pharmaceutical manufacturers and researchers.
02
Physical and chemical properties
- Melting point: approx. 150-155°C
- Solubility: Soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO), limited solubility in water
- Stability: Shows good stability under standard storage conditions, ensuring longer shelf life and reliable performance in various applications
These properties not only enhance the efficacy of Ibrutinib Intermediates in chemical synthesis, but also ensure that manufacturers can achieve consistent results during the production process.
- Solubility: Soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO), limited solubility in water
- Stability: Shows good stability under standard storage conditions, ensuring longer shelf life and reliable performance in various applications
These properties not only enhance the efficacy of Ibrutinib Intermediates in chemical synthesis, but also ensure that manufacturers can achieve consistent results during the production process.
1. High Purity: Our 2-[Hydroxy-(4-phenoxy-phenyl)-Methylene]-Malononitrile is produced using advanced purification technology, resulting in high product purity. This is critical for pharmaceutical applications, as impurities can adversely affect the safety and efficacy of the final product.
2. Wide Application: This compound is a key intermediate in the synthesis of various pharmaceutical compounds and is a valuable asset for manufacturers seeking to innovate and expand their product lines. It has a wide range of uses and can be used in a variety of applications in drug development.
3. Regulatory Compliance: We adhere to strict international quality standards to ensure that Ibrutinib Intermediates meets regulatory requirements for all pharmaceutical ingredients. This compliance guarantees product safety and efficacy, providing a smoother approval process for our customers.
4. Cost Effective: By sourcing Ibrutinib Intermediates directly from our integrated production facilities, we can offer competitive pricing without compromising on quality. This cost effectiveness enables our customers to optimize production budgets while maintaining high standards.
5. Expert Support: Our experienced team of professionals is committed to providing exceptional customer support. We offer expert consulting in formulation development and regulatory compliance, ensuring our customers have the resources they need to succeed in the competitive pharmaceutical market.
6. Flexible Order Quantity: We understand that each customer has unique needs. Therefore, we offer flexible order quantities to accommodate both small-scale and large-scale production needs. This adaptability ensures that you can get the right amount of Ibrutinib Intermediates for your specific project.
2. Wide Application: This compound is a key intermediate in the synthesis of various pharmaceutical compounds and is a valuable asset for manufacturers seeking to innovate and expand their product lines. It has a wide range of uses and can be used in a variety of applications in drug development.
3. Regulatory Compliance: We adhere to strict international quality standards to ensure that Ibrutinib Intermediates meets regulatory requirements for all pharmaceutical ingredients. This compliance guarantees product safety and efficacy, providing a smoother approval process for our customers.
4. Cost Effective: By sourcing Ibrutinib Intermediates directly from our integrated production facilities, we can offer competitive pricing without compromising on quality. This cost effectiveness enables our customers to optimize production budgets while maintaining high standards.
5. Expert Support: Our experienced team of professionals is committed to providing exceptional customer support. We offer expert consulting in formulation development and regulatory compliance, ensuring our customers have the resources they need to succeed in the competitive pharmaceutical market.
6. Flexible Order Quantity: We understand that each customer has unique needs. Therefore, we offer flexible order quantities to accommodate both small-scale and large-scale production needs. This adaptability ensures that you can get the right amount of Ibrutinib Intermediates for your specific project.
In conclusion, 2-[Hydroxy-(4-phenoxy-phenyl)-Methylene]-Malononitrile is a high-quality pharmaceutical intermediate that plays a vital role in the synthesis of effective drug products. With its superior physical and chemical properties, regulatory compliance, and the backing of a dedicated support team, our products stand out as a reliable choice for pharmaceutical manufacturers.
Choose Ibrutinib Intermediates for your next formulation or synthesis project and experience the difference in quality and performance. Contact us today to learn more about our products and how we can support your pharmaceutical needs.
Choose Ibrutinib Intermediates for your next formulation or synthesis project and experience the difference in quality and performance. Contact us today to learn more about our products and how we can support your pharmaceutical needs.

![330792-68-2 Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]- 外观.png](https://ecdn6.globalso.com/upload/p/2209/image_other/2025-04/330792-68-2-propanedinitrile-2-hydroxy-4-phenoxyphenyl-methylene-1.png)

